Possible breakout target around $43. ( one of ARKG stocks)
- Buy call option strike $35 , July-16 @ $1
Nvitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.
Please note:
- I'm just sharing my view. it's not a recommendation for buying or selling.